Status:
COMPLETED
Avanz Phleum Pratense Maintenance Dose
Lead Sponsor:
ALK-Abelló A/S
Conditions:
Allergic Rhinoconjunctivitis
Eligibility:
All Genders
18-64 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of the trial is to evaluate the efficacy of two dosing schedules of Avanz SQ+ (Standardised Quality) Phleum pratense compared to placebo in subjects with grass pollen induced allergic rhin...
Eligibility Criteria
Inclusion
- A history of grass pollen allergy
- Positive skin prick test to grass
- Positive Immunoglobulin E test to grass
Exclusion
- Other allergies overlapping the grass pollen season
- Severe Asthma (defined as a Forced expiratory volume in 1 second (FEV1) below 70 % after adequate treatment)
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT01438827
Start Date
September 1 2011
End Date
January 1 2013
Last Update
January 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UntersuchungsZentrum für Dermatologie, Allergologie und Asthma
Berlin, State of Berlin, Germany, 14050